Bausch + Lomb Corporation (BLCO)

USD 18.24

(-3.24%)

Operating Expenses Summary of Bausch + Lomb Corporation

  • Bausch + Lomb Corporation's latest annual operating expenses in 2023 was 2.37 Billion USD , up 13.36% from previous year.
  • Bausch + Lomb Corporation's latest quarterly operating expenses in 2024 Q3 was 595 Million USD , down -3.88% from previous quarter.
  • Bausch + Lomb Corporation reported a annual operating expenses of 2.02 Billion USD in annual operating expenses 2022, up 3.94% from previous year.
  • Bausch + Lomb Corporation reported a annual operating expenses of 1.95 Billion USD in annual operating expenses 2021, up 6.72% from previous year.
  • Bausch + Lomb Corporation reported a quarterly operating expenses of 586 Million USD for 2024 Q1, down -8.86% from previous quarter.
  • Bausch + Lomb Corporation reported a quarterly operating expenses of 619 Million USD for 2024 Q2, up 5.63% from previous quarter.

Annual Operating Expenses Chart of Bausch + Lomb Corporation (2023 - 2018)

Historical Annual Operating Expenses of Bausch + Lomb Corporation (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 2.37 Billion USD 13.36%
2022 2.02 Billion USD 3.94%
2021 1.95 Billion USD 6.72%
2020 1.82 Billion USD -8.0%
2019 1.98 Billion USD 3.27%
2018 1.92 Billion USD 0.0%

Peer Operating Expenses Comparison of Bausch + Lomb Corporation

Name Operating Expenses Operating Expenses Difference
Alcon Inc. 4.2 Billion USD 43.584%
AptarGroup, Inc. 814.37 Million USD -191.512%
Baxter International Inc. 5.27 Billion USD 54.97%
Becton, Dickinson and Company 6.04 Billion USD 60.741%
Haemonetics Corporation 526.66 Million USD -350.761%
Envista Holdings Corp 1.15 Billion USD -106.309%
ResMed Inc. 1.36 Billion USD -73.491%
Teleflex Incorporated 1.08 Billion USD -118.96%
Warby Parker Inc. 437.22 Million USD -442.976%
West Pharmaceutical Services, Inc. 454 Million USD -422.907%